Editorial
Pyrotinib as a therapeutic for HER2-positive breast cancer
Translational Cancer Research
2023;
12
(6)
:1376-1379
.
(30 June 2023)
Original Article
Preoperative low-density lipoprotein cholesterol as a predictor of favorable prognosis in patients with clear cell renal cell carcinoma
Translational Cancer Research
2023;
12
(6)
:1380-1391
.
(30 June 2023)
A signature of cuproptosis-related lncRNAs predicts prognosis and provides basis for future anti-tumor drug development in breast cancer
Translational Cancer Research
2023;
12
(6)
:1392-1410
.
(30 June 2023)
Establishment and validation of a prognostic nomogram for patients with renal cell carcinoma based on SEER and TCGA database
Translational Cancer Research
2023;
12
(6)
:1411-1421
.
(30 June 2023)
Decreased zinc-fingers and homeoboxes family expression was associated with unfavorable outcomes and immune infiltration in lung adenocarcinoma
Translational Cancer Research
2023;
12
(6)
:1422-1440
.
(30 June 2023)
Identification and evaluation of a risk model predicting the prognosis of breast cancer based on characteristic signatures
Translational Cancer Research
2023;
12
(6)
:1441-1451
.
(30 June 2023)
The association between cholecystectomy and the risk of colorectal cancer: an updated systematic review and meta-analysis of cohort studies
Translational Cancer Research
2023;
12
(6)
:1452-1465
.
(30 June 2023)
Screening of novel biomarkers for breast cancer based on WGCNA and multiple machine learning algorithms
Translational Cancer Research
2023;
12
(6)
:1466-1489
.
(30 June 2023)
Efficacy, cardiotoxicity and factors affecting pathologic complete response of neoadjuvant chemotherapy with anthracycline-containing verses anthracycline-free regimens plus dual HER2 blockade for HER2-positive early-stage breast cancer: a retrospective study
Translational Cancer Research
2023;
12
(6)
:1490-1502
.
(30 June 2023)
TFF3 promotes clonogenic survival of colorectal cancer cells through upregulation of EP4 via activation of STAT3
Translational Cancer Research
2023;
12
(6)
:1503-1515
.
(30 June 2023)
Comprehensive pan-cancer analysis identifies FHL2 associated with poor prognosis in lung adenocarcinoma
Translational Cancer Research
2023;
12
(6)
:1516-1534
.
(30 June 2023)
Identifying a prognostic model and screening of potential natural compounds for acute myeloid leukemia
Translational Cancer Research
2023;
12
(6)
:1535-1551
.
(30 June 2023)
Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis
Translational Cancer Research
2023;
12
(6)
:1552-1564
.
(30 June 2023)
Bioactivity of recombinant humanized monoclonal antibody against HER2 in-vivo and in-vitro and its mechanism of action in ovarian cancer
Translational Cancer Research
2023;
12
(6)
:1565-1576
.
(30 June 2023)
Association between serum albumin levels and survival in elderly patients with diffuse large B-cell lymphoma: a single-center retrospective study
Translational Cancer Research
2023;
12
(6)
:1577-1587
.
(30 June 2023)
In vitro study of piwi interaction RNA-31106 promoting breast carcinogenesis by regulating METTL3-mediated m6A RNA methylation
Translational Cancer Research
2023;
12
(6)
:1588-1601
.
(30 June 2023)
Viral hepatitis increases the risk of cholangiocarcinoma: a systematic review and meta-analysis
Translational Cancer Research
2023;
12
(6)
:1602-1616
.
(30 June 2023)
Review Article
A narrative review about CDK4/6 inhibitors in the setting of drug resistance: updates on biomarkers and therapeutic strategies in breast cancer
Translational Cancer Research
2023;
12
(6)
:1617-1634
.
(30 June 2023)
Analysis of the metastatic mechanism and progress in the treatment of breast cancer liver metastasis: a narrative review
Translational Cancer Research
2023;
12
(6)
:1635-1646
.
(30 June 2023)
Erratum
Erratum to long non-coding RNA SNHG17 promotes gastric cancer progression by inhibiting P15 and P16
Translational Cancer Research
2023;
12
(6)
:1647-1648
.
(30 June 2023)
